NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Clinical trials for NON-MUSCLE INVASIVE BLADDER NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER NEOPLASMS trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bladder cancer device could delay return of tumors without removing bladder
Disease control OngoingThis study tests a new treatment called TAR-200 for people with a high-risk type of bladder cancer that came back after standard therapy (BCG). Participants either receive TAR-200 or standard chemotherapy placed directly into the bladder. The goal is to see if TAR-200 can keep th…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New hope for bladder cancer patients: early access to TAR-200
Disease control APPROVED_FOR_MARKETINGThis program provides early access to TAR-200, an experimental treatment, for people with high-risk non-muscle invasive bladder cancer who have run out of standard options. Participants must have tried all other treatments and cannot join a clinical trial. The goal is to offer a …
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
Pee test could spare bladder cancer patients painful scopes
Diagnosis OngoingThis study looks at whether a urine test called BladMetrix can safely detect bladder cancer coming back in people who have had surgery. About 500 adults with non-muscle invasive bladder cancer will provide extra urine samples during their regular check-ups over two years. The tes…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Sponsor: Oslo University Hospital • Aim: Diagnosis
Last updated Jun 15, 2026 19:03 UTC